ClinicalTrials.govcontrolled
Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma
ClinicalTrials.gov study NCT01597908. IPD Sharing: YES. Countries: 28. Publications: 5.
ShareScore
40/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8